What is the difference between Bituva and Jifukang?

The main ingredients of Bictegravir (Biktegravir tablets) are bictegravir, emtricitabine and tenofovir alafenamide. Among them, bictegravir is an integrase inhibitor, emtricitabine is a nucleoside reverse transcriptase inhibitor, and tenofovir alafenamide is an upgraded version of tenofovir with better pharmacokinetic properties and fewer side effects.

Jefukang (Ecoin-Pinti Tablets) is mainly composed of elvitegravir, cobicistat, tenofovir alafenamide and emtricitabine. It also contains the two ingredients tenofovir alafenamide and emtricitabine, but the integrase inhibitor part uses elvitegravir, and the synergist cobicistat is added.

Bituvi (Bikronol Tablets) is mainly used to treat HIV-1 infection and is one of the first-choice drugs for the complete treatment of HIV-1 infected adult patients. Due to its potent antiviral effect and good safety, it is widely used in the long-term treatment of HIV infected patients.

Jiefukan (Ecoin Protein Tablets) is also used to treat HIV-1 infection, and is not limited to adult patients. Jefukang's ability to rapidly reduce viral load and low side effects enable it to perform well both in the initial stage of treatment and in blocking treatment. In addition, it can also be used to block HIV exposure to high-risk behaviors.

The side effects of Bituvi (Bikronol Tablets) are relatively small, but long-term use may still cause some adverse reactions, such as depression, dizziness, headache, diarrhea, nausea, rash, itching, joint pain, fatigue, etc. In addition, uncommon reactions such as hematological anemia, hepatobiliary hyperbilirubinemia, and angioedema may occur. But generally speaking, Bikeren Prenol Tablets have advantages in terms of efficacy, safety, convenience, drug resistance, etc., and there is no hidden danger of hyperlipidemia when taken for a long time.

Although Jifukang (Aikaonbindi Tablets) also has significant antiviral effects, it has relatively many side effects. Long-term use may cause adverse reactions such as abnormal dreams, headache, dizziness, diarrhea, vomiting, and rash. In addition, central nervous system symptoms such as dizziness and depression, as well as blood system reactions such as anemia and leukopenia, may also occur. However, these side effects are tolerable in most patients and can be alleviated by adjusting the dose or treatment regimen.

Bituvi (Bikernopinol Tablets) mainly achieves anti-viral effects by activating its own anti-viral mechanism. The integrase inhibitor bictegravir in its component can block the integration of HIVvirusDNA into the host cell genome, thus preventing the replication and spread of the virus. At the same time, the nucleoside reverse transcriptase inhibitors emtricitabine and tenofovir alafenamide further block viral replication by inhibiting the activity of viral reverse transcriptase.

Jifukang (Aikaonbindi Tablets) mainly achieves anti-viral effects by blocking viral replication. Elvitegravir is also an integrase inhibitor, but its mechanism of action is slightly different from bictegravir. In addition, Jefukang also contains the synergist cobicistat, which can enhance the effect of other antiviral ingredients, thereby reducing viral load faster and reducing the occurrence of viral resistance.

In addition to considering the above factors, when choosing to use Bituvail or Jefucan, individualized assessment is also required based on the patient's specific situation. For example, the patient's age, gender, underlying diseases, liver and kidney function, and drug allergy history may affect the selection and use of drugs.